3188 results for «231»
3188 results
Valve-in-valve TAVI
21 May 2025 – From EuroPCR 2025
Explore valve-in-valve TAVI strategies for patients with degenerated surgical valves, focusing on small aortic annuli. This session covers the impact of valve design and implant techniques, valve fracturing methods, procedural outcomes of repeat TAVI, and mid-to-long-term results from the ACCURATE NEO 2 study.
AsiaPCR/SingLIVE 2017: closing Ceremony and Awards
21 Jan 2017 – From AsiaPCR/SingLIVE 2017
Consult the Closing ceremony and awards session from AsiaPCR/SingLIVE 2017, where W. Wijns addresses the subject of what to expect in the field of Interventional Cardiology in 2017, and the speakers present the award winners of this year's best clinical cases namely R. Fukuhara, Japan, W....
Chairperson
Chairperson
AsiaPCR/SingLIVE 2017: Opening Ceremony
19 Jan 2017 – From AsiaPCR/SingLIVE 2017
Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.
Chairperson
Opening Ceremony: PCR London Valves 2018
10 Sep 2018 – From PCR London Valves 2018
Join J. J. Bax, B. Prendergast and J. Fajadet for the opening ceremony of PCR London Valves 2018 and find out more about the global challenge of the increasing burden of heart disease and the new technologies for the treatment of SHD.
Closing Ceremony and Highlights of the Course: PCR London Valves 2018
11 Sep 2018 – From PCR London Valves 2018
Join B. Prendergast for the closing ceremony of PCR London Valves 2018 and discover the course highlights!
PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
